VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,380,000 | -11.7% | 6,901 | +1.3% | 0.21% | -7.1% |
| Q2 2015 | $1,562,000 | +16.8% | 6,814 | +0.9% | 0.23% | +10.8% |
| Q1 2015 | $1,337,000 | +68.0% | 6,750 | +20.1% | 0.20% | +55.7% |
| Q4 2014 | $796,000 | +9.3% | 5,618 | +1.7% | 0.13% | 0.0% |
| Q3 2014 | $728,000 | -3.1% | 5,526 | -5.2% | 0.13% | -4.4% |
| Q2 2014 | $751,000 | -38.3% | 5,832 | -38.9% | 0.14% | -45.4% |
| Q1 2014 | $1,218,000 | +4.3% | 9,548 | -7.1% | 0.25% | +1.6% |
| Q4 2013 | $1,168,000 | +1.7% | 10,283 | -5.9% | 0.25% | -0.8% |
| Q3 2013 | $1,148,000 | +22.5% | 10,926 | 0.0% | 0.25% | +11.2% |
| Q2 2013 | $937,000 | – | 10,926 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |